Bioqual ROA 2012-2025 | BIOQ
Current and historical return on assets (ROA) values for Bioqual (BIOQ) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Bioqual ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-11-30 | $0.00B | $0.06B | 1.66% |
| 2025-08-31 | $0.00B | $0.06B | 0.00% |
| 2025-05-31 | $0.00B | $0.06B | -1.78% |
| 2025-02-28 | $0.00B | $0.06B | -3.56% |
| 2024-11-30 | $0.00B | $0.06B | -5.26% |
| 2024-08-31 | $0.00B | $0.06B | -3.49% |
| 2024-05-31 | $0.00B | $0.06B | 0.00% |
| 2024-02-29 | $0.00B | $0.06B | 0.00% |
| 2023-11-30 | $0.00B | $0.06B | -1.65% |
| 2023-08-31 | $0.00B | $0.06B | 0.00% |
| 2023-05-31 | $0.00B | $0.06B | 0.00% |
| 2023-02-28 | $0.00B | $0.06B | 4.72% |
| 2022-11-30 | $0.01B | $0.06B | 7.87% |
| 2022-08-31 | $0.01B | $0.06B | 7.94% |
| 2022-05-31 | $0.01B | $0.06B | 8.30% |
| 2022-02-28 | $0.01B | $0.06B | 8.66% |
| 2021-11-30 | $0.01B | $0.06B | 9.13% |
| 2021-08-31 | $0.01B | $0.05B | 9.62% |
| 2021-05-31 | $0.01B | $0.05B | 11.71% |
| 2021-02-28 | $0.01B | $0.05B | 9.90% |
| 2020-11-30 | $0.01B | $0.05B | 10.00% |
| 2020-08-31 | $0.01B | $0.05B | 10.15% |
| 2020-05-31 | $0.00B | $0.04B | 10.96% |
| 2020-02-29 | $0.00B | $0.03B | 16.33% |
| 2019-11-30 | $0.00B | $0.01B | 24.00% |
| 2019-08-31 | $0.00B | $0.00B | 600.00% |
| 2019-05-31 | $0.00B | $0.00B | 600.00% |
| 2019-02-28 | $0.00B | $0.01B | 46.15% |
| 2018-11-30 | $0.00B | $0.01B | 61.54% |
| 2018-08-31 | $0.00B | $0.01B | 61.54% |
| 2018-05-31 | $0.00B | $0.01B | 61.54% |
| 2018-02-28 | $0.00B | 0 | 0.00% |
| 2017-11-30 | $0.00B | 0 | 0.00% |
| 2017-08-31 | $0.00B | 0 | 0.00% |
| 2017-05-31 | $0.00B | 0 | 0.00% |
| 2017-02-28 | $0.00B | 0 | 0.00% |
| 2016-11-30 | $0.00B | 0 | 0.00% |
| 2016-08-31 | $0.00B | 0 | 0.00% |
| 2016-05-31 | $0.00B | 0 | 0.00% |
| 2016-02-29 | $0.00B | 0 | 0.00% |
| 2015-11-30 | $0.00B | 0 | 0.00% |
| 2015-08-31 | $0.00B | 0 | 0.00% |
| 2015-05-31 | $0.00B | 0 | 0.00% |
| 2015-02-28 | $0.00B | 0 | 0.00% |
| 2014-08-31 | $0.00B | 0 | 0.00% |
| 2014-05-31 | $0.00B | 0 | 0.00% |
| 2013-11-30 | $0.00B | 0 | 0.00% |
| 2013-08-31 | $0.00B | 0 | 0.00% |
| 2013-05-31 | $0.00B | 0 | 0.00% |
| 2012-05-31 | $0.00B | 0 | 0.00% |
| 2012-02-29 | $0.00B | 0 | 0.00% |
| 2011-11-30 | $0.00B | 0 | 0.00% |
| 2011-08-31 | $0.00B | 0 | 0.00% |
| 2011-05-31 | $0.00B | 0 | 0.00% |
| 2011-02-28 | $0.00B | 0 | 0.00% |
| 2010-11-30 | $0.00B | 0 | 0.00% |
| 2010-08-31 | $0.00B | 0 | 0.00% |
| 2010-05-31 | $0.00B | 0 | 0.00% |
| 2009-11-30 | $0.00B | 0 | 0.00% |
| 2009-08-31 | $0.00B | 0 | 0.00% |
| 2008-05-31 | $0.00B | $0.00B | 0.00% |
| 2002-05-31 | $0.00B | $0.00B | 0.00% |
| 2002-02-28 | $0.00B | $0.01B | 0.00% |
| 2001-11-30 | $0.00B | $0.01B | 0.00% |
| 2001-08-31 | $0.00B | $0.01B | 0.00% |
| 2001-05-31 | $0.00B | $0.01B | 0.00% |
| 2001-02-28 | $0.00B | $0.01B | 0.00% |
| 2000-11-30 | $0.00B | $0.01B | 0.00% |
| 2000-08-31 | $0.00B | $0.01B | 0.00% |
| 2000-05-31 | $0.00B | $0.01B | 0.00% |
| 2000-02-29 | $0.00B | $0.01B | 0.00% |
| 1999-11-30 | $0.00B | $0.01B | 0.00% |
| 1999-08-31 | $0.00B | $0.01B | 0.00% |
| 1999-05-31 | $0.00B | $0.01B | 0.00% |
| 1999-02-28 | $0.00B | $0.01B | 0.00% |
| 1998-11-30 | $0.01B | $0.01B | 244.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.034B | $0.049B |
| BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |